Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/26/25 16:47 | 12/27/23 | TARS | Health | BioPrd | Biological Products, (No Diag | Azamian Bobak R. | CA | DO | P,CEO,Bo | 4 | S.dm | -1,944 | 39.96 | 0 | -49 | 884 | I | |||||||||||||||
3/20/25 21:49 | 3/18/25 | TARS | Health | BioPrd | Biological Products, (No Diag | Mottiwala Aziz | CA | O | Chief Co | 2 | S.dm | -652 | 42.51 | 0 | -15 | 65 | D | |||||||||||||||
3/20/25 21:49 | 3/18/25 | TARS | Health | BioPrd | Biological Products, (No Diag | Neervannan Seshadri | CA | O | COO | 2 | S.dm | -512 | 41.12 | 0 | -12 | 80 | D | |||||||||||||||
3/20/25 21:49 | 3/18/25 | TARS | Health | BioPrd | Biological Products, (No Diag | Wahl Bryan | CA | O | GC | 2 | S.dm | -600 | 42.45 | 0 | -14 | 52 | D | |||||||||||||||
3/20/25 21:48 | 3/18/25 | TARS | Health | BioPrd | Biological Products, (No Diag | Whitfield Dianne C. | CA | O | CHRO | 2 | S.dm | -453 | 41.12 | 0 | -11 | 46 | D | |||||||||||||||
3/20/25 21:48 | 3/18/25 | TARS | Health | BioPrd | Biological Products, (No Diag | Farrow Jeffrey S | CA | O | See Rema | 2 | S.dm | -465 | 32.83 | 0 | -14 | 22 | D | |||||||||||||||
8/14/24 16:34 | 8/12/24 | TARS | Health | BioPrd | Biological Products, (No Diag | Link William J Phd | CA | D | 1 | S | -913 | 26.08 | 0 | -35 | 178 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |